Voydeya Interactions
There are 193 drugs known to interact with Voydeya (danicopan). Of the total drug interactions, 39 are major, 141 are moderate, and 13 are minor.
Medications known to interact with Voydeya
Note: Showing generic names only.
A
- abrocitinib
- adalimumab
- afatinib
- alefacept
- alemtuzumab
- aliskiren
- allogeneic processed thymus tissue
- alpelisib
- alvimopan
- anakinra
- apixaban
- armodafinil
- artesunate
- asparaginase erwinia chrysanthemi
- asparaginase escherichia coli
- atorvastatin
- azathioprine
B
- baricitinib
- bcg
- bedaquiline
- belinostat
- berotralstat
- betrixaban
- bifidobacterium infantis
- black cohosh
- bosutinib
- brentuximab
- brewer's yeast
C
- cabazitaxel
- calaspargase pegol
- canakinumab
- cannabidiol
- cat's claw
- ceritinib
- certolizumab
- cladribine
- clofarabine
- cobimetinib
- colchicine
- cyclosporine
D
- dabigatran
- daclatasvir
- daclizumab
- darolutamide
- daunorubicin
- daunorubicin liposomal
- delafloxacin
- denosumab
- deucravacitinib
- dextromethorphan
- digoxin
- dimethyl fumarate
- diroximel fumarate
- docetaxel
- doxorubicin
- doxorubicin liposomal
E
- echinacea
- edoxaban
- efalizumab
- efavirenz
- elagolix
- eliglustat
- eltrombopag
- empagliflozin
- enfortumab vedotin
- epirubicin
- erlotinib
- erythromycin
- etanercept
- etoposide
- etrasimod
- everolimus
F
G
I
- idarubicin
- idelalisib
- imatinib
- indacaterol
- infliximab
- interferon beta-1a
- interferon beta-1b
- irinotecan
- irinotecan liposomal
- isoniazid
- ixabepilone
K
L
- lactobacillus acidophilus
- lactobacillus reuteri
- lactobacillus rhamnosus
- lactobacillus rhamnosus gg
- lapatinib
- larotrectinib
- leflunomide
- lemborexant
- letermovir
- levoketoconazole
- linagliptin
- lomitapide
- loperamide
- lurasidone
- lusutrombopag
M
N
- nadofaragene firadenovec
- naldemedine
- naloxegol
- naltrexone
- natalizumab
- nilotinib
- nintedanib
- niraparib
O
P
- paclitaxel
- pazopanib
- pegaspargase
- peginterferon beta-1a
- pexidartinib
- ponesimod
- posaconazole
- pralsetinib
- prucalopride
Q
R
- ranolazine
- relugolix
- remdesivir
- repotrectinib
- rifampin
- rifaximin
- rilonacept
- rimegepant
- riociguat
- ripretinib
- ritlecitinib
- ritonavir
- rivaroxaban
- roflumilast
- romidepsin
- rosuvastatin
- rucaparib
S
- saccharomyces boulardii lyo
- saxagliptin
- selexipag
- silodosin
- siponimod
- sipuleucel-T
- sirolimus
- sirolimus protein-bound
- sulfasalazine
T
- tacrolimus
- talazoparib
- talimogene laherparepvec
- tenofovir
- tenofovir alafenamide
- tepotinib
- terfenadine
- teriflunomide
- thioguanine
- ticagrelor
- tipranavir
- tofacitinib
- tolvaptan
- topotecan
- trabectedin
- trametinib
U
V
- valoctocogene roxaparvovec
- vemurafenib
- venetoclax
- vinblastine
- vincristine
- vincristine liposome
- vinorelbine
- vitamin e
- voclosporin
Z
More about Voydeya (danicopan)
- Voydeya consumer information
- Compare alternatives
- Pricing & coupons
- Imprints, shape & color data
- FDA approval history
- Drug class: selective immunosuppressants
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.